Therapeutic management of acute intracerebral haemorrhage

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 18, 2007, Pages 3097-3116

  Asdaghi, N ^a   Manawadu, D ^a   Butcher, K ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

anticoagulant; antihypertensive; haemostatic agent; hypertension

Indexed keywords

HEMOSTATIC AGENT;

ACUTE DISEASE; BRAIN HEMORRHAGE; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ACUTE DISEASE; CEREBRAL HEMORRHAGE; HEMOSTATICS; HUMANS;

EID: 40949112039     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.8.18.3097     Document Type: Review

References (191)

1. BUTCHER K, LAIDLAW J: Current intracerebral haemorrhage management. J. Clin. Neurosci. (2003) 10(2):158-167.
2. THRIFT AG, DONNAN GA, MCNEIL JJ: Epidemiology of intracerebral hemorrhage. Epidemiol. Rev. (1995) 17(2):361-381.
3. ALBERS GW, AMARENCO P, EASTON JD, SACCO RL, TEAL P: Antithrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest (2004) 126 (3 Suppl.):S483-S512.
4. FAYAD PB, AWAD IA: Surgery for intracerebral hemorrhage. Neurolog y (1998) 51(3 Suppl. 3):S69-S73.
5. DENNIS MS, BURN JPS, SANDERCOCK PAG, BAMFORD JM, WADE DT, WARLOW CP: Long-term survival after fi rst-ever stroke: the Oxfordshire community stroke project. Stroke (1993) 24:796-800.
6. BRODERICK JP: Natural history of primary intracerebral hemorrhage. In: Stroke: Populations, Cohorts, and Clinical Trials. Whisnant JP (Ed.), Butterworth-Heinemann, Oxford (1993):154-173.
7. BRODERICK JP: Handbook of Neuroepidemiology . Marcel Decker, Inc., New York (1994).
8. COUNSELL C, BOONYAKARNKUL S, DENNIS M: Primary intracerebral haemorrhage in the Oxfordshire community stroke project, 2: prognosis. Cerebrovasc. Dis. (1995) 5:26-34.
9. HALPIN SF, BRITTON JA, BYRNE JV, CLIFTON A, HART G, MOORE A: Prospective evaluation of cerebral angiography and computed tomography in cerebral haematoma. J. Neurol. Neurosurg. Psychiatry (1994) 57(10):1180-1186.
10. THRIFT AG, DONNAN GA, MCNEIL JJ: Heavy drinking, but not moderate or intermediate drinking, increases the risk of intracerebral hemorrhage. Epidemiology (1999) 10(3):307-312.
11. BOGOUSSLAVSKY J, VAN MELLE G, REGLI F: The Lausanne stroke registry: analysis of 1,000 consecutive patients with fi rst stroke. Stroke (1988) 19(9): 1083-1092.
12. WOO D, SAUERBECK LR, KISSELA BM et al. : Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 33(5): 1190-1195.
13. FISHER CM: Pathological observations in hypertensive cerebral hemorrhage. J. Neuropathol. Exp. Neurol. (1971) 30(3):536-550.
14. BUTCHER K, BAIRD T, PARSONS M, DAVIS S: Medical management of intracerebral hemorrhage. Neurosurg Quart. (2002) 12(4):261-278.
15. VINTERS HV, GILBERT JJ: Cerebral amyloid angiopathy: incidence and complications in the aging brain II. The distribution of amyloid vascular changes. Stroke (1983) 14(6):924-928.
16. BRODERICKJP, BROTTT, TOMSICK T, LEACH A: Lobar hemorrhage in the elderly. The undiminishing importance of hyertension. Stroke (1993) 24:49-51.
17. VINTERS HV: Cerebral amyloid angiopathy. A critical review. Stroke (1987) 18(2):311-324.
18. BAILEY RD, HART RG, BENAVENTE O, PEARCE LA: Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology (2001) 56(6):773-777.
19. HART RG, BOOP BS, ANDERSON DC: Oral anticoagulants and intracranial hemorrhage: facts and hypotheses. Stroke (1995) 26(8): 1471-1477.
20. HART RG, TONARELLI SB, PEARCE LA: Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke (2005) 36(7): 1588-1593.
21. JUVELA S: Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Arch. Neurol. (1996) 53:734-740.
22. ANONYMOUS: Risk factors for stroke and effi cacy of antithrombotic therapy in atrial fi brillation. Analysis of pooled data from fi ve randomized controlled trials. Arch. Intern. Med. (1994) 154(13):1449-1457.
23. PRYSTOWSKY EN: Management of patients with atrial fi brillation. A statement for healthcare professionals. From the subcommittee on electrocardiography and electrophysiology, American heart association. Circulation (1996) 93(6):1262-1277.
24. GORTER JW: Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke prevention in reversible ischemia trial (SPIRIT). European atrial fi brillation trial (EAFT) study groups. Neurology (1999) 53(6):1319-1327.
25. LEVINE MN: Hemorrhagic complications of anticoagulant treatment. Chest (2001) 119(1 Suppl.):S108-S121.
26. BERWAERTS J, ROBB OJ, JEFFERS TA, WEBSTER J: Intracerebral haemorrhages and oral anticoagulation in the north of Scotland. Scott. Med. J. (2000) 45(4):101-104.
27. ECKMAN MH, ROSAND J, KNUDSEN KA, SINGER DE, GREENBERG SM: Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 34(7):1710-1716.
28. WOO D, SAUERBECK LR, KISSELA BM et al. : Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 33:1190-1196.
29. PUNTHAKEE X, DOOBAY J, ANAND SS: Oral-anticoagulant-related intracerebral hemorrhage. Thromb. Res. (2002) 108(1):31-36.
30. NILSSON OG, LINDGREN A, STAHL N, BRANDT L, SAVELAND H: Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J. Neurol. Neurosurg. Psychiatry (2000) 69(5):601-607.
31. FLAHERTY ML, KISSELA B,WOO D et al. : The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology (2007) 68(2):116-121.
32. Indications for fi brinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic therapy trialists' (FTT) collaborative group. Lancet (1994) 343(8893):311-322.
33. OHMAN EM, HARRINGTON RA, CANNON CP, AGNELLI G, CAIRNS JA, KENNEDY JW: Intravenous thrombolysis in acute myocardial infarction. Chest (2001) 119 (1 Suppl.):S253-S277.
34. SLOAN MA, SILA CA, MAHAFFEY KW et al. : Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation (1998) 98(14):1376-1382.
35. HACKE W, BROTT T, CAPLAN L et al.: Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology (1999) 53(7 Suppl. 4):S3-S14.
36. SCHELLINGER PD, JANSEN O, FIEBACH JB, HACKE W, SARTOR K: A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke (1999) 30(4):765-768.
37. KIDWELL CS, SAVER JL, GOUGH KJ et al. : Hemorrhage early MRI evaluation (HEME) study (Abstract, American Stroke Association). Stroke (2002).
38. BRODERICK JP: Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality Stroke (1993) 24(7):987-993.
39. HELWEG-LARSEN S, SOMMER W, STRANGE P, LESTER P, BOYSEN G: Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke(1984) 15(6): 1045-1048.
40. NILSSON OG, LINDGREN A, BRANDT L, SAVELAND H: Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defi ned population. J. Neurosurg. (2002) 97:531-536.
41. FUJIIY, TANAKA R, TAKEUCHI S, KOIKE T, MINAKAWA T, SASAKI O: Hematoma enlargement in spontaneous intracerebral hemorrhage. J. Neurosurg. (1994) 80(1):51-57.
42. KAZUI S, NARITOMI H, YAMAMOTO H, SAWADA T, YAMAGUCHI T: Enlargement of spontaneous intracerebral hemorrhage: incidence and time course. Stroke (1996) 27(10):1783-1787.
43. BROTT T, BRODERICKJ, KOTHARI R et al. : Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 28:1-5.
44. KAZUI S, MINEMATSU K, YAMAMOTO H, SAWADA T, YAMAGUCHI T: Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke (1997) 28:2370-2375.
45. FUJIIY, TAKEUCHI S, SASAKI O, MINAKAWA T, TANAKA R: Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke (1998) 29:1160-1166.
46. TAKIZAWA K, SUZUKI A, NAGATE K et al. : Blood pressure control in acute stages of hypertensive intracerebral hemorrhage to prevent growth of hematoma. In: Brain Hemorrhage '99. Yasui N (Ed.), NEURON publishing, Tokyo (2002): 11-18.
47. GOLDSTEIN JN, FAZEN LE, SNIDER R et al. : Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology (2007) 68(12):889-894.
48. WADA R, AVIV RI, FOXAJ et al.: CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke (2007) 38(4):1257-1262.
49. SHACKFORD SR, ZHUANG J, SCHMOKER J: Intravenous fl uid tonicity: effect on intracranial pressure, cerebral blood fl ow, and cerebral oxygen delivery in focal brain injury. J. Neurosurg. (1992) 76(1):91-98.
50. KIMURA K, IGUCHI Y, INOUE T et al.: Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J. Neurol. Sci. (2007) 255(1-2):90-94.
51. SCHWARZ S, HAFNER K, ASCHOFF A, SCHWAB S: Incidence and prognostic signifi cance of fever following intracerebral hemorrhage. Neurology (2000) 54(2):354-361.
52. SCHWAB S, SCHWARZ S, SPRANGER M, KELLER E, BERTRAM M, HACKE W: Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke (1998) 29(12):2461-2466.
53. AIYAGARI V, DIRINGER MN: Fever control and its impact on outcomes: what is the evidence? J. Neurol. Sci. (2007).
54. BAMFORD J, DENNIS M, SANDERCOCK P, BURN J, WARLOW C: The frequency, causes and timing of death within 30 days of a fi rst stroke: the Oxfordshire community stroke project. J. Neurol. Neurosurg. Psychiatry (1990) 53(10):824-829.
55. SILVER FL, NORRIS JW, LEWIS AJ, HACHINSKI VC: Early mortality following stroke: a prospective review. Stroke (1984) 15:492-496.
56. BUCCI MN, PAPADOPOULOS SM, CHEN JC, CAMPBELL JA, HOFF JT: Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial. Surg. Neurol. (1989) 32(4):285-288.
57. BOEER A, VOTH E, HENZE T, PRANGE HW: Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J. Neurol. Neurosurg. Psychiatry (1991) 54(5):466-467.
58. FAUGHT E, PETERS D, BARTOLUCCI A, MOORE L, MILLER PC: Seizures after primary intracerebral hemorrhage. Neurology (1989) 39:1089-1093.
59. BLADIN C, ALEXANDROV AV, BELLAVANCE A et al. : Seizures after stroke a prospective multicenter study. Arch. Neurol. (2000) 57:1617-1622.
60. KILPATRICK CJ: Epileptic seizures in acute stroke. Arch. Neurol. (1990) 47(2):157-160.
61. FERNANDES HM, GREGSON B, SIDDIQUE S, MENDELOW AD: Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke (2000) 31(10):2511-2516.
62. PRASAD K: Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst. Rev. (2000) (2):CD000200.
63. HANKEY GJ: Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke (1997) 28(11):2126-2132.
64. MENDELOWAD, GREGSON BA, FERNANDES HM et al. : Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet (2005) 365(9457):387-397.
65. Major ongoing stroke trials: STITCH II. Stroke (2007) 38(6):E39-E47.
66. DUNNE JW, CHAKERA T, KERMODE S: Cerebellar haemorrhage-diagnosis and treatment: a study of 75 consecutive cases. Q. J. Med. (1987) 64(245):739-754.
67. BRODERICK J, CONNOLLYS, FELDMANN E et al. : Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American heart association/American stroke association stroke council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group. Stroke (2007) 38(6):2001-2023.
68. VAN LOON J, VAN CALENBERGH F, GOFFIN J, PLETS C: Controversies in the management of spontaneous cerebellar haemorrhage. A consecutive series of 49 cases and review of the literature. Acta Neurochir. (Wien.) (1993) 122(3-4): 187-193.
69. KASE CS: Cerebellar hemorrhage. Intracerebral Hemorrhage. Kase CS, Caplan L (Eds), Butterworth-Heinemann, Newton, MA (1994):425-443.
70. SYPERT GW: Cerebellar hemorrhage and infarction. Compr. Ther. (1977) 3(4):42-47.
71. MORIOKAJ, FUJII M, KATO S et al.: Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy. Surg. Neurol (2006) 65(1):67-72; discussion 72-63.
72. AUER LM, DEINSBERGER W, NIEDERKORN K et al.: Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J. Neurosurg. (1989) 70(4):530-535.
73. AMANO K, KAWAMURA H, TANIKAWA T et al. : Surgical treatment of hypertensive intracerebral haematoma by CT-guided stereotactic surgery. Acta Neurochir. Suppl. (Wien.) (1987) 39:41-44.
74. THIEX R, ROHDE V, ROHDE I et al.: Frame-based and frameless stereotactic hematoma puncture and subsequent fi brinolytic therapy for the treatment of spontaneous intracerebral hemorrhage. J. Neurol. (2004) 251(12):1443-1450.
75. VESPA P, MCARTHUR D, MILLER C et al. : Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit. Care (2005) 2(3):274-281.
76. TEERNSTRA OP, EVERS SM, LODDER J, LEFFERS P, FRANKE CL, BLAAUW G: Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke (2003) 34(4):968-974.
77. BRODERICK JP, DIRINGER MN, HILL MD et al. : Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 38(3):1072-1075.
78. ARNOUT J, HOYLAERTS MF, LIJNEN HR: Haemostasis: Handb. Exp. Pharmacol. (2006) (176 Part 2):1-41.
79. SORIMACHI T, FUJII Y, MORITA K, TANAKA R: Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifi brinolytic agents and strict blood pressure control. J. Neurosurg. (2007) 106(2):250-254.
80. NIELSEN VG, CANKOVIC L, STEENWYK BL: Epsilon-aminocaproic acid inhibition of fi brinolysis in vitro: should the 'therapeutic' concentration be reconsidered? Blood Coagul. Fibrinolysis (2007) 18(1):35-39.
81. GHOSH K, NAIR AP, JIJINA F, MADKAIKAR M, SHETTY S, MOHANTY D: Intracranial haemorrhage in severe haemophilia: prevalence and outcome in a developing country. Haemophilia (2005) 11(5):459-462.
82. PIRIYAWAT P, MORGENSTERN LB, YAWN DH, HALL CE, GROTTA JC: Treatment of acute intracerebral hemorrhage with epsilon-aminocaproic acid: a pilot study. Neurocrit. Care (2004) 1(1):47-51.
83. LONGSTAFF C: Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifi brinolytic agents. Blood Coagul. Fibrinolysis (1994) 5(4):537-542.
84. MANNUCCI PM: Hemostatic drugs. N. Engl. J. Med. (1998) 339(4):245-253.
85. HILLMAN J, FRIDRIKSSON S, NILSSON O, YU Z, SAVELAND H, JAKOBSSON KE: Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J. Neurosurg. (2002) 97(4):771-778.
86. ROOS Y: Antifi brinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR study group. Neurology (2000) 54(1):77-82.
87. STROOBANDT G, LAMBERT O, MENARD E: The association of tranexamic acid and nimodipine in the pre-operative treatment of ruptured intracranial aneurysms. Acta Neurochir. (Wien.) (1998) 140(2):148-160.
88. ROOS YB, RINKEL GJ, VERMEULEN M, ALGRA A, VAN GIJN J: Antifi brinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst. Rev. (2003) (2):CD001245.
89. ROOS Y, RINKEL G,VERMEULEN M, ALGRA A, VAN GIJN J: Antifi brinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. Stroke (2003) 34(9):2308-2309.
90. SORIMACHI T, FUJII Y, MORITA K, TANAKA R: Rapid administration of antifi brinolytics and strict blood pressure control for intracerebral hemorrhage. Neurosurgery (2005) 57(5):837-844.
91. FRIEDERICH PW, HENNY CP, MESSELINK EJ et al. : Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet (2003) 361(9353):201-205.
92. ROBERTS HR, MONROE DM, WHITE GC: The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood (2004) 104(13):3858-3864.
93. HEDNER U: Mechanism of action of factor VIIa in the treatment of coagulopathies. Semin. Thromb. Hemost (2006) 32(Suppl. 1):77-85.
94. HEDNER U: Mechanism of action of recombinant activated factor VII: an update. Semin. Hematol. (2006) 43 (1 Suppl. 1):S105-S107.
95. ROSE L: Recombinant factor VIIa: review of current "off license" indications and implications for practice. AACN Adv. Crit. Care (2007) 18(2):141-148.
96. BARLETTA JF, AHRENS CL, TYBURSKI JG, WILSON RF: A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients. J. Trauma (2005) 58(3):646-651.
97. BOFFARD KD, RIOU B, WARREN B et al. : Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J. Trauma (2005) 59(1):8-15; discussion 15-18.
98. MAYER SA, BRUN NC, BEGTRUP K et al. : Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. (2005) 352(8):777-785.
99. MAYER SA, BRUN NC, BRODERICK J et al. : Recombinant activated factor VII for acute intracerebral hemorrhage: US Phase IIA trial. Neurocrit. Care (2006) 4(3):206-214.
100. MAYER SA: Recombinant activated factor VII for acute intracerebral hemorrhage. Stroke (2007)38(2):763-767.
101. TELLEZ H, BAUER RB: Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke (1973) 4(4):541-546.
102. POUNGVARIN N, BHOOPAT W, VIRIYAVEJAKUL A et al. : Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N. Engl. J. Med. (1987) 316(20):1229-1233.
103. YU YL, KUMANA CR, LAUDER IJ et al.: Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke (1992) 23(7):967-971.
104. GRUCHOW HW, ANDERSON AJ, BARBORIAK JJ: Postmenopausal use of estrogen and occlusion of coronary arteries. Am. Heart J. (1988) 115:954-963.
105. BERECZKI D, LIU M, PRADO GF, FEKETE I: Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke (2000) 31(11):2719-2722.
106. BRODERICK JP, ADAMS HP Jr, BARSAN W et al. : Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American heart association. Stroke (1999) 30:905-915.
107. MISRA UK, KALITA J, RANJAN P, MANDAL SK: Mannitol in intracerebral hemorrhage: a randomized controlled study. J. Neurol. Sci. (2005) 34(1-2):41-45.
108. THE COPENHAGEN AFASAK STUDY: Risk factors for thromboembolic complications of chronic atrial fi brillation. Arch. Intern. Med. (1990) 150:819-821.
109. EAFT (EUROPEAN ATRIAL FIBRILLATION TRIAL) STUDY GROUP: Secondary prevention in non-rheumatic atrial fi brillation after transient ischaemic attack or minor stroke. Lancet (1993) 342:1255-1262.
110. GAGE BF, WATERMAN AD, SHANNON W, BOECHLER M, RICH MW, RADFORD MJ: Validation of clinical classifi cation schemes for predicting stroke: results from the National registry of atrial fi brillation. JAMA (2001) 285(22):2864-2870.
111. VAN WALRAVEN C, HART RG, WELLS GA et al. : A clinical prediction rule to identify patients with atrial fi brillation and a low risk for stroke while taking aspirin. Arch. Intern. Med. (2003) 163(8):936-943.
112. PHAN TG, KOH M, WIJDICKS EF: Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch. Neurol. (2000) 57(12):1710-1713.
113. TARDY B, TARDY-PONCET B, LAPORTE-SIMITSIDIS S et al.: Evolution of blood coagulation and fi brinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double-blind randomized study. Br. J. Haematol. (1997) 96(1):174-178.
114. BRODERICK J, CONNOLLY S, FELDMANN E et al.: Guidelines for the management of spontaneous intracerebral hemorrhage in adults. 2007 update. A guideline from the American heart association, American stroke association stroke council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group. Strokeaha (2007).
115. MAKRIS M, GREAVES M, PHILLIPS WS, KITCHEN S, ROSENDAAL FR, PRESTON EF: Emergency oral anticoagulant reversal: the relative effi cacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb. Haemost. (1997) 77(3):477-480.
116. YASAKA M, SAKATA T, NARITOMI H, MINEMATSU K: Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb. Res. (2005) 115(6):455-459.
117. RIESS HB, MEIER-HELLMANN A, MOTSCH J, ELIAS M, KURSTEN FW, DEMPFLE CE: Prothrombin complex concentrate (Octaplex(R)) in patients requiring immediate reversal of oral anticoagulation. Thromb. Res. (2007).
118. MENACHE D, BEHRE HE, ORTHNER CL et al.: Coagulation factor IX concentrate: method of preparation and assessment of potential in vivo thrombogenicity in animal models. Blood (1984) 64(6):1220-1227.
119. BUTLER AC, TAIT RC: Management of oral anticoagulant-induced intracranial haemorrhage. Blood Rev. (1998) 12(1):35-44.
120. FREDRIKSSON K, NORRVING B, STROMBLAD LG: Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke (1992) 23(7):972-977.
121. SJOBLOM L, HARDEMARK HG, LINDGREN A et al. : Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke (2001) 32(11):2567-2574.
122. CANNEGIETER SC, ROSENDAAL FR, BRIET E: Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation (1994) 89(2):635-641.
123. AGUILAR MI, HART RG, KASE CS et al. : Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin. Proc. (2007) 82(1):82-92.
124. ESTOL CJ, KASE CS: Need for continued use of anticoagulants after intracerebral hemorrhage. Curr. Treat. Options Cardiovasc. Med. (2003) 5(3):201-209.
125. CANNEGIETER SC, VAN DER MEER FJ, BRIET E, ROSENDAAL FR: Warfarin and aspirin after heart-valve replacement. N. Engl. J. Med. (1994) 330(7):507-508; author reply 508-509.
126. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA stroke study group. Stroke (1997) 28(11):2109-2118.
127. REPORT OFTHE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF N PRACTIE ADVISORY: Thrombolytic therapy for acute ischemic stroke-summary statement. Neurology (1996) 47:835-839.
128. STEINER T, KASTE M, FORSTING M et al. : Recommendations for the management of intracranial haemorrhage. Part I. Spontaneous intracerebral haemorrhage. The European stroke initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc. Dis. (2006) 22(4):294-316.
129. WALLACE JD, LEVY LL: Blood pressure after stroke. JAMA (1981) 246:2177-2180.
130. HARPER G, CASTLEDEN CM, POTTER JF: Factors affecting changes in blood pressure after acute stroke. Stroke (1994) 25:1726-1729.
131. ONG TZ, RAYMOND AA: Risk factors for stroke and predictors of one-month mortality. Singapore Med. J. (2002) 43:517-521.
132. FOGELHOLM R, AVIKAINEN S, MURROS K: Prognostic value and determinants of fi rst-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke (1997) 28:1396-1400.
133. PORTENOY RK, LIPTON RB, BERGER AR, LESSER ML, LANTOS G: Intracerebral haemorrhage: a model for the prediction of outcome. J. Neurol. Neurosurg. Psychiatry (1987) 50:976-979.
134. TUHRIM S, DAMBROSIA JM, PRICE TR et al. : Prediction of intracerebral hemorrhage survival. Ann. Neurol. (1988) 24:258-263.
135. BRODERICK JP, BROTTTG, DULDNER JE, TOMSICK T, HUSTER G: Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke (1993) 24:987-993.
136. CARLBERG B, ASPLUND K, HAGG E: The prognostic value of admission blood pressure in patients with acute stroke. Stroke (1993) 24:1372-1375.
137. DANDAPANI BK, SUZUKI S, KELLEY RE, REYES-IGLESIAS Y, DUNCAN RC: Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke (1995) 26:21-24.
138. LEIRA R, DÁVALOS A, SILVA Y et al.: Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology (2004) 63:461-467.
139. QURESHI AI, SAFDAR K, WEIL J et al.: Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke (1995) 26:1764-1767.
140. TERAYAMA Y, TANAHASHI N, FUKUUCHI Y, GOTOH F: Prognostic value of admission blood pressure in patients with intracerebral hemorrhage: Keio cooperative stroke study. Stroke (1997) 28:1185-1188.
141. MEYER JS, BAUER RB: Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs. Neurology (1962) 12:36-47.
142. DUNNE JW, CHAKERAT, KERMODE S: Cerebellar haemorrhage, diagnosis and treatment: a study of 75 consecutive cases. QJM (1987) 64:739-754.
143. QURESHI AI, BLIWISE DL, BLIWISE NG, AKBAR MS, UZEN G, FRANKEL MR: Rate of 24-h blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit. Care Med. (1999) 27:480-485.
144. VEMMOS KN, TSIVGOULIS G, SPENGOS K et al. : U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J. Intern. Med. (2004) 255:257-265.
145. OKUMURA K, OHYA Y, MAEHARA A, WAKUGAMI K, ISEKI K, TAKISHITA S: Effects of blood pressure levels on case fatality after acute stroke. J. Hypertens. (2005) 23(6): 1217-1223.
146. CARHUAPOMA JR, ULATOWSKIJA: Blood pressure control after intracerebral hemorrhage: have we reached the target? Crit. Care Med. (2006) 34(7):2023-2024.
147. OHWAKI K, YONO E, NAGASHIMA H, HIRATA M, NAKAGOMI T, TAMURA A: Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke (2004) 35:1353-1367.
148. GEBEL JM Jr, JAUCH EC, BROTT TG et al. : Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke (2002) 33:2631-2635.
149. GEBEL JM Jr, JAUCH EC, BROTT TG et al. : Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke (2002) 33:2636-2641.
150. BUTCHER K, BAIRD T, MACGREGOR L, DESMOND P, TRESS B, DAVIS S: Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke (2004) 35:1879-1885.
151. SCHELLINGER PD, FIEBACH JB, HOFFMANN K et al. : Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke (2003) 34(7): 1674-1679.
152. MENDELOW AD: Mechanisms of ischemic brain damage with intracerebral hemorrhage. Stroke (1993) 24(12 suppl.):I115-I117; discussion I118-I119.
153. ADAMS RE, POWERS WJ: Management of hypertension in acute intracerebral hemorrhage. Crit. Care Clin. (1997) 13(1): 131-161.
154. MAYER SA, THOMAS CE, DIAMOND BE: Asymmetry of intracranial hemodynamics as an indicator of mass effect in acute intracerebral hemorrhage: a transcranial doppler study Stroke (1996) 27(10):1788-1792.
155. SUTHERLAND GR, AUERRN: Primary intracerebral hemorrhage. J. Clin. Neurosci. (2006) 13(5):511-517.
156. BATJER HH, REISCHJS, ALLEN BC, PLAIZIER LJ, SU CJ: Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch. Neurol. (1990) 47(10): 1103-1106.
157. BRODERICK JP, ADAMS HP Jr, BARSAN W et al. : Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American heart association. Stroke (1999) 30(4):905-915.
158. HACKE W, KASTE M, BOGOUSSLAVSKY J et al: European stroke initiative recommendations for stroke management: update 2003. Cerebrovasc. Dis. (2003) 16:311-337.
159. BATH P, CHALMERS J, POWERS W et al : International society of hypertension (ISH): statement on the management of blood pressure in acute stroke. J. Hypertens. (2003) 21:665-672.
160. BLOOD PRESSURE IN ACUTE STROKE COLLABORATION (BASC): Interventions for deliberately altering blood pressure in acute stroke (Cochraneeview). In: The Cochrane Library John Wiley & Sons, Chichester ( 2003 ).
161. MANN G, HANKEY GJ, CAMERON D: Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke (1999) 30:744-748.
162. DI CARLO A, LAMASSA M, BALDERESCHI M et al. : Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke (2003) 34:1114-1119.
163. VARON J, MARIK PE: The diagnosis and management of hypertensive crises. Chest (2000) 118(1):214-227.
164. PATEL RV, KERTLAND HR, JAHNS BE, ZAROWITZ BJ, MLYNAREK ME, FAGAN SC: Labetalol: response and safety in critically ill hemorrhagic stroke patients. Ann. Pharmacother. (1993) 27(2):180-181.
165. QURESHI AI, MOHAMMAD YM, YAHIA AM et al. : A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J. Intensive Care Med. (2005) 20(1):34-42.
166. CHEN ZM, PAN HC, CHEN YP et al.: Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet (2005) 366(9497):1622-1632.
167. ANTMAN EM, ANBE DT, ARMSTRONG PW et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines (Writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J. Am. Coll. Cardiol. (2004) 44(3):671-719.
168. VAN DE WERF F, ARDISSINO D, BETRIU A et al. : Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European society of cardiology. Eur. Heart J. (2003) 24(1):28-66.
169. WIENBERGEN H, ZEYMER U, GITT AK et al. : Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction. Am. J. Cardiol. (2007) 99(9):1208-1211.
170. POLDERMANS D, BOERSMA E, BAX JJ et al. : The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N. Engl. J. Med. (1999) 341(24):1789-1794.
171. POLDERMANS D, BOERSMA E, BAX JJ et al. : Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur. Heart J. (2001) 22(15):1353-1358.
172. BARER DH, CRUICKSHANK JM, EBRAHIM SB, MITCHELL JR: Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. BMJ (1988) 296:737-741.
173. HIRSCHL MM, BINDER M, BUR A et al. : Safety and effi cacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intensive Care Med. (1997) 23(8):885-888.
174. QURESHI AI, HARRIS-LANE P, KIRMANI JF et al. : Treatment of acute hypertension in patients with intracerebral hemorrhage using American heart association guidelines. Crit. Care Med. (2006) 34(7):1975-1980.
175. QURESHI AI: Antihypertensive treatment of acute cerebral hemorrhage (ATACH): rationale and design. Neurocrit. Care (2007) 6(1):56-66.
176. RINKEL GJ, FEIGIN VL, ALGRA A, VAN DEN BERGH WM, VERMEULEN M, VAN GIJN J: Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst. Rev. (2005) (1):CD000277.
177. AHMED N, WAHLGREN NG: Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes. Cerebrovasc. Dis (2003) 15(4):235-243.
178. BUTTERWORTH RJ, CLUCKIE A, JACKSON SH, BUXTON-THOMAS M, BATH PM: Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc. Dis. (1998) 8(3):158-165.
179. BATH PM, WILLMOT M, LEONARDI-BEE J, BATH FJ: Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst. Rev. (2002) (4):CD000398.
180. BATH P, PATHANSALI R, IDDENDEN R, BATH F: The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc. Dis. (2001) 11:265-272.
181. Major ongoing stroke trials: effi cacy of nitric oxide in stroke (ENOS) trial. Stroke (2006) 37(2):E18-E26.
182. DIRINGER MN, EDWARDS DF: Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit. Care Med. (2001) 29(3):635-640.
183. FUENTES B, DIEZ-TEJEDOR E: The advantages of a stroke unit in the treatment of intracerebral hemorrhage. Rev. Neurol. (2000) 31(2):171-174.
184. MORGENSTERN L, FRANKOWSKI R, SHEDDEN P, PASTEUR W, GROTTA J: Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology (1998) 51(5):1359-1363.
185. YASAKA M, SAKATA T, MINEMATSU K, NARITOMI H: Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb. Res. (2002) 108(1):25-30.
186. BOULIS NM, BOBEK MP, SCHMAIER A, HOFF JT: Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery (1999) 45(5):1113-1118; discussion 1118-1119.
187. CARTMILL M, DOLAN G, BYRNE JL, BYRNE PO: Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br. J. Neurosurg. (2000) 14(5):458-461.
188. HUTTNER HB, SCHELLINGER PD, HARTMANN M et al.: Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke (2006) 37(6):1465-1470.
189. SORENSEN B, JOHANSEN P, NIELSEN GL, SORENSEN JC, INGERSLEV J: Reversal of the International normalized ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul. Fibrinolysis (2003) 14(5):469-477.
190. FREEMAN WD, BROTT TG, BARRETT KM et al.: Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin. Proc. (2004) 79(12):1495-1500.
191. BRODY DL, AIYAGARI V, SHACKLEFORD AM, DIRINGER MN: Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit. Care (2005) 2(3):263-267.